[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Analgesics in Latvia

November 2020 | 26 pages | ID: AB11ABC90D5EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
When lockdown restrictions began to take effect in March, sales of analgesics received a welcome boost. Latvian consumers feared running out of products considered essential or that might help mitigate symptoms of COVID-19, stockpiling analgesics in some cases. Furthermore, Latvians were wearier of visits to the doctor in 2020, in an effort to avoid raising their risk of infection or overburdening an already stretched healthcare system. Consequently, consumers were even more likely to self-medic...

Euromonitor International's Analgesics in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
KEY DATA FINDINGS
2020 IMPACT
Consumers fear the worst, buying analgesics to combat symptoms of COVID-19
Waning interest in Ibumetin helps GSK Consumer Healthcare overtake Nycomed Latvia in 2020
Nurofen gains popularity with parents
RECOVERY AND OPPORTUNITIES
Self-medication remains strong due to problems accessing doctors
Ibuprofen remains a the most popular systemic analgesic in the forecast period, valued for its many uses
Ageing will lead to growth in topical analgesics/anaesthetic, despite depopulation in the forecast period
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Penetration of Private Label by Category: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2019-2020
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources


More Publications